Compare KNF & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNF | ITGR |
|---|---|---|
| Founded | 1917 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 3.0B |
| IPO Year | 2023 | 2000 |
| Metric | KNF | ITGR |
|---|---|---|
| Price | $79.17 | $82.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $97.38 | $91.14 |
| AVG Volume (30 Days) | 563.2K | ★ 821.5K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.76 | ★ 2.89 |
| Revenue | ★ $3,146,012,000.00 | $1,853,637,000.00 |
| Revenue This Year | $9.15 | $1.69 |
| Revenue Next Year | $5.53 | $6.53 |
| P/E Ratio | $29.88 | ★ $29.37 |
| Revenue Growth | ★ 8.52 | 7.98 |
| 52 Week Low | $58.72 | $62.00 |
| 52 Week High | $101.02 | $127.56 |
| Indicator | KNF | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 44.26 |
| Support Level | $76.74 | $82.78 |
| Resistance Level | $79.11 | $88.36 |
| Average True Range (ATR) | 3.20 | 2.92 |
| MACD | -0.80 | -0.23 |
| Stochastic Oscillator | 15.13 | 10.11 |
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. The segments of the company include West, Mountain, Central, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.